CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government

Qué ocurrió

CVS Pharmacy Inc., a Rhode Island-based pharmacy chain, and its related corporate entities (collectively, CVS) have agreed to pay $315 million to resolve allegations that, from October 17, 2013 through December 2, 2025, CVS illegally filled prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act (CSA), and then sought payment for many of those invalid prescriptions...

Por que importa

The development may change operating conditions or market expectations around Regulation. Further confirmation and measurable outcomes matter.

Entidades afectadas

Ver evidencia

2 articulos · 1 informe original · 1 independientes

1. U.S. Department of JusticeFuente primaria · Respalda · EN · 100%
   CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government ↗13 oct 2026, 8:00
2. U.S. Department of JusticeFuente primaria · Respalda · EN · 80%
   CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government ↗13 oct 2026, 8:00

Afirmaciones

• CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government Observado

Conflictos

No se detectaron conflictos importantes en la evidencia disponible.

Cronología

1. 13 de octubre de 2026 a las 8:00Primera publicación

Movimiento del mercado posterior al evento

La reacción del mercado aún no está disponible para este activo y periodo.

Explicación de puntuaciones